Retroperitoneoscopic microwave ablation of renal hamartoma: Middle-term results

Abstract

The safety and efficacy of retroperitoneoscopic microwave ablation (MWA) in the treatment of renal hamartoma were evaluated. From July 2007 to July 2009, a total of 16 cases of renal hamartoma were treated with retroperitoneoscopic MWA. Peri- and post-operative findings were observed. Middle-term efficacy was assessed by contrast-enhanced computerized tomography (CT) in follow-up period. All patients received MWA of 1–5 points. The mean operative time was 85 min and the mean blood loss was 65 mL. During a median follow-up of 16 months, no evidence of disease recurrence was observed despite of incomplete ablation in 1 case. Retroperitoneoscopic MWA is a relatively simple procedure with less impact to renal function and less complication. The outcome of middle-term follow-up is satisfactory. Thus, retroperitoneoscopic MWA appears to be a safe and effective technique for renal hamartoma in selected patients.

Keywords

retroperitoneoscope / renal hamartoma / microwave ablation

References

[1] HechtE.M., IsraelG.M., KrinskyG.A., et al.. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging. Radiology, 2004, 232(2): 373-378

[2] VricellaG.J., PonskyL.E., CadedduJ.A.. Ablative technologies for urologic cancers. Urol Clin North Am, 2009, 36(2): 163-178

[3] RamanJ.D., HallD.W., CadedduJ.A.. Renal ablative therapy: radiofrequency ablation and cryoablation. J Surg Oncol, 2009, 100(8): 639-644

[4] WenC.C., NakadaS.Y.. Energy ablative techniques for treatment of small renal tumors. Curr Opin Urol, 2006, 16(5): 321-326

[5] ClarkP.E., WoodruffR.D., ZagoriaR.J., et al.. Microwave ablation of renal parenchymal tumors before nephrectomy: phase I study. AJR Am J Roentgenol, 2007, 188(5): 1212-1214

[6] BraceC.L.. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: What are the differences?. Curr Probl Diagn Radiol, 2009, 38(3): 135-143

[7] CarrafielloG., LaganaD., ManginiM., et al.. Microwave tumors ablation: Principles, clinical applications and review of preliminary experiences. Int J Surg, 2008, 6(Suppl1): S65-S69

[8] LaesekeP.F., LeeF.T.Jr, SampsonL.A., et al.. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J Vasc Interv Radiol, 2009, 20(9): 1224-1229

[9] NaitoS., NakashimaM., KimotoY., et al.. Application of microwave tissue coagulator in partial nephrectomy for renal cell carcinoma. J Urol, 1998, 159(3): 960-962

[10] YoshimuraK., OkuboK., IchiokaK., et al.. Laparoscopic partial nephrectomy with a microwave tissue coagulator for small renal tumor. J Urol, 2001, 165(6Pt1): 1893-1896

[11] KesslerO.J., GillionG., NeumanM., et al.. Management of renal angiomyolipoma: Analysis of 15 cases. Eur Urol, 1998, 33(6): 572-575

[12] LiangP., WangY., ZhangD., et al.. Ultrasound guided percutaneous microwave ablation for small renal cancer: Initial experience. J Urol, 2008, 180(3): 844-848

[13] LeibovichB.C., BluteM.L., ChevilleJ.C., et al.. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J Urol, 2004, 171(3): 1066-1070

[14] ZhangD., DongB., WangY., et al.. Percutaneous microwave ablation or nephrectomy for VX-2 carcinoma in rabbit kidney. J Urol, 2009, 182(4): 1588-1593

[15] GongE.M., OrvietoM.A., ZornK.C., et al.. Comparison of laparoscopic and open partial nephrectomy in clinical T1a renal tumors. J Endourol, 2008, 22(5): 953-957